GAYATRI BIOORGANICS LTD.

Gayatri BioOrganics Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending June 30, 2026. This measure is to prevent insider trading during the period leading up to and immediately following the announcement of financial results. A board meeting will be convened to approve these results.

Gayatri BioOrganics Ltd has submitted revised audited financial results for the quarter and year ended March 31, 2026, due to typographical errors in the previously submitted results. The revision, following a Board Meeting on May 19, 2026, has no impact on the company's financial performance, profitability, or cash flows. The company has requested the exchange to replace the earlier filed version with the revised results.

Gayatri BioOrganics Ltd has submitted revised audited financial results for the quarter and year ended March 31, 2026, following the identification of typographical errors in the previously submitted results. The company clarified that these corrections do not impact the financial performance, profitability, cash flows, or any other material financial information. The revised results have been submitted to the exchange to replace the earlier version.

Gayatri BioOrganics Ltd re-appointed M/s. Vas & Co., Chartered Accountants, as their Internal Auditors for the financial year 2026-27. The decision was made during the Board Meeting held on May 19, 2026. The board also approved the audited financial results for the quarter and year ended March 31, 2026, and the Auditor’s Report along with the declaration as per Regulation 33 of SEBI (LODR) Regulations, 2015.

Gayatri Bioorganics Ltd's board meeting on May 19, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. M/s. Vas & Co., Chartered Accountants, were appointed as Internal Auditors for FY 2026-27. The company reported a loss of ₹111.18 Lakhs for the year ended March 31, 2026.

Gayatri BioOrganics Ltd's audited financial results for the year ended March 31, 2026, reveal a net loss of ₹111.18 lakhs. The company's board, in a meeting held on May 19, 2026, approved these results along with the auditor's report. Additionally, M/s. Vas & Co., Chartered Accountants, were appointed as internal auditors for the financial year 2026-27.

Gayatri Bioorganics Ltd has scheduled a Board of Directors meeting on May 19, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting will take place at the company's registered office in Hyderabad.

Gayatri BioOrganics Ltd has announced the postponement of its Board of Directors meeting, which was originally scheduled for April 15, 2026. The primary agenda for this meeting was to consider a proposal for the reduction of capital. The company cited "unavoidable circumstances" as the reason for the delay. A new date for the Board Meeting will be communicated to the stock exchange at a later time. This postponement could introduce uncertainty regarding the timeline for the company's capital restructuring plans.

Gayatri BioOrganics Ltd has announced that its Board of Directors will meet on April 15, 2026, to consider and approve a Reduction of Capital. The meeting is scheduled in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will also consider any other matter with the permission of the chair. The trading window for dealing in the securities of the company is closed for all designated persons, their immediate relatives, and all connected persons covered under the Company’s Code of Conduct from April 1, 2026, till 48 hours after the declaration of audited Financial Results for the Quarter and financial year ended 31.03.2026.

Gayatri BioOrganics Limited (Scrip code: 524564) has announced the closure of its trading window for all designated persons, their immediate relatives, and all connected persons covered under the Company’s Code of Conduct. The closure will commence from 01.04.2026 and will last until 48 hours after the declaration of audited Financial Results for the Quarter and financial year ended 31.03.2026. The Board Meeting is scheduled to consider and approve the audited Financial Results for the quarter and year ended March 31, 2026. An intimation regarding the notice of the Board Meeting will be sent separately to the Stock Exchange.